These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23740934)

  • 1. Progress in the biological understanding and management of breast cancer-associated central nervous system metastases.
    Dawood S; Gonzalez-Angulo AM
    Oncologist; 2013 Jun; 18(6):675-84. PubMed ID: 23740934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human epidermal growth factor receptor 2-positive breast cancer and central nervous system metastases.
    Leyland-Jones B
    J Clin Oncol; 2009 Nov; 27(31):5278-86. PubMed ID: 19770385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Current and Evolving Role of Radiation Therapy for Central Nervous System Metastases from Breast Cancer.
    Tanguturi S; Warren LEG
    Curr Oncol Rep; 2019 Apr; 21(6):50. PubMed ID: 30993546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capecitabine therapy of central nervous system metastases from breast cancer.
    Ekenel M; Hormigo AM; Peak S; Deangelis LM; Abrey LE
    J Neurooncol; 2007 Nov; 85(2):223-7. PubMed ID: 17611719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast Cancer in the Central Nervous System: Multidisciplinary Considerations and Management.
    Lin NU; Gaspar LE; Soffietti R
    Am Soc Clin Oncol Educ Book; 2017; 37():45-56. PubMed ID: 28561683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment.
    Kim HJ; Im SA; Keam B; Kim YJ; Han SW; Kim TM; Oh DY; Kim JH; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Noh DY; Heo DS; Park IA; Bang YJ; Ha SW
    J Neurooncol; 2012 Jan; 106(2):303-13. PubMed ID: 21938531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival of breast cancer patients with synchronous or metachronous central nervous system metastases.
    Ho VK; Gijtenbeek JM; Brandsma D; Beerepoot LV; Sonke GS; van der Heiden-van der Loo M
    Eur J Cancer; 2015 Nov; 51(17):2508-16. PubMed ID: 26277099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast cancer metastasis to the central nervous system.
    Weil RJ; Palmieri DC; Bronder JL; Stark AM; Steeg PS
    Am J Pathol; 2005 Oct; 167(4):913-20. PubMed ID: 16192626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining prognosis for women with breast cancer and CNS metastases by HER2 status.
    Dawood S; Broglio K; Esteva FJ; Ibrahim NK; Kau SW; Islam R; Aldape KD; Yu TK; Hortobagyi GN; Gonzalez-Angulo AM
    Ann Oncol; 2008 Jul; 19(7):1242-1248. PubMed ID: 18334512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and prognosis of breast cancer patients with brain metastases according to intrinsic subtype.
    Kuba S; Ishida M; Nakamura Y; Yamanouchi K; Minami S; Taguchi K; Eguchi S; Ohno S
    Jpn J Clin Oncol; 2014 Nov; 44(11):1025-31. PubMed ID: 25156682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CNS metastases in breast cancer.
    Lin NU; Bellon JR; Winer EP
    J Clin Oncol; 2004 Sep; 22(17):3608-17. PubMed ID: 15337811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central nervous system metastases in women who receive trastuzumab-based therapy for metastatic breast carcinoma.
    Bendell JC; Domchek SM; Burstein HJ; Harris L; Younger J; Kuter I; Bunnell C; Rue M; Gelman R; Winer E
    Cancer; 2003 Jun; 97(12):2972-7. PubMed ID: 12784331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of central nervous system metastases as a first site of metastatic disease in breast cancer patients treated in the neoadjuvant trials GeparQuinto and GeparSixto.
    Laakmann E; Witzel I; Fasching PA; Rezai M; Schem C; Solbach C; Tesch H; Klare P; Schneeweiss A; Salat C; Zahm DM; Blohmer JU; Ingold-Heppner B; Huober J; Hanusch C; Jackisch C; Reinisch M; Untch M; von Minckwitz G; Nekljudova V; Müller V; Loibl S
    Breast Cancer Res; 2019 May; 21(1):60. PubMed ID: 31077239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review.
    Ricciardi GRR; Russo A; Franchina T; Schifano S; Mastroeni G; Santacaterina A; Adamo V
    BMC Cancer; 2018 Jan; 18(1):97. PubMed ID: 29370839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system metastases in patients with HER2-positive metastatic breast cancer: incidence, treatment, and survival in patients from registHER.
    Brufsky AM; Mayer M; Rugo HS; Kaufman PA; Tan-Chiu E; Tripathy D; Tudor IC; Wang LI; Brammer MG; Shing M; Yood MU; Yardley DA
    Clin Cancer Res; 2011 Jul; 17(14):4834-43. PubMed ID: 21768129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and management of central nervous system metastases from breast cancer.
    Chang EL; Lo S
    Oncologist; 2003; 8(5):398-410. PubMed ID: 14530493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CNS complications of breast cancer: current and emerging treatment options.
    Kaal EC; Vecht CJ
    CNS Drugs; 2007; 21(7):559-79. PubMed ID: 17579499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolated central nervous system metastases in patients with HER2-overexpressing advanced breast cancer treated with first-line trastuzumab-based therapy.
    Burstein HJ; Lieberman G; Slamon DJ; Winer EP; Klein P
    Ann Oncol; 2005 Nov; 16(11):1772-7. PubMed ID: 16150805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local and systemic therapy in breast cancer patients with central nervous system metastases.
    Wellerdieck NEA; Wessels P; Los M; Sonke GS; Tromp E; Brandsma D
    Breast Cancer Res Treat; 2022 Jul; 194(2):365-384. PubMed ID: 35680734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminal subtypes predict improved survival following central nervous system metastasis in patients with surgically managed metastatic breast carcinoma.
    Wiens AL; Martin SE; Bertsch EC; Vance GH; Stohler RA; Cheng L; Badve S; Hattab EM
    Arch Pathol Lab Med; 2014 Feb; 138(2):175-81. PubMed ID: 24476516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.